Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ritch

Showing results (341-350 of 383) with videos related to

Pageof 39
Sort By:
Urologic Oncology|December 23, 2019
Timing of adjuvant chemotherapy and overall survival following radical cystectomyJoshua S Jue, Tulay Koru-Sengul, Feng Miao, et al.
BJUI Compass|August 19, 2024
Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant TherapyTarek Ajami, Sunwoo Han, Ruben Blachman-Braun, et al.
The Journal of Urology|June 6, 2019
Reply by AuthorsC R Ritch, M S Cookson, P E Clark, et al.
The Journal of Urology|October 26, 2018
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled TrialChad R Ritch, Michael S Cookson, Peter E Clark, et al.
The British Journal of Ophthalmology|July 9, 2010
Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomographyC K Leung, P-M Palmiero, R N Weinreb, et al.
Urology|April 22, 2014
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancerChad R Ritch, Chaochen You, Alexandra T May, et al.
BJUI Compass|April 18, 2024
Clinical variables associated with major adverse cardiac events following radical cystectomyAaron A Gurayah, Ruben Blachman-Braun, Christopher J Machado, et al.
Minerva Urology and Nephrology|February 7, 2020
Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysisJoshua S Jue, Tulay Koru-Sengul, Feng Miao, et al.
Cancers|October 28, 2023
The Influence of the Microbiome on Urological Malignancies: A Systematic ReviewJoao G Porto, Maria Camila Suarez Arbelaez, Brandon Pena, et al.
Urology|November 13, 2019
Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic AdenocarcinomaOleksii A Iakymenko, Isabella Lugo, Deukwoo Kwon, et al.
Pageof 39

Showing results (341-350 of 383) with videos related to

Sort By:
Pageof 39
Urologic Oncology|December 23, 2019
Timing of adjuvant chemotherapy and overall survival following radical cystectomyJoshua S Jue, Tulay Koru-Sengul, Feng Miao, et al.
BJUI Compass|August 19, 2024
Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant TherapyTarek Ajami, Sunwoo Han, Ruben Blachman-Braun, et al.
The Journal of Urology|June 6, 2019
Reply by AuthorsC R Ritch, M S Cookson, P E Clark, et al.
The Journal of Urology|October 26, 2018
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled TrialChad R Ritch, Michael S Cookson, Peter E Clark, et al.
The British Journal of Ophthalmology|July 9, 2010
Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomographyC K Leung, P-M Palmiero, R N Weinreb, et al.
Urology|April 22, 2014
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancerChad R Ritch, Chaochen You, Alexandra T May, et al.
BJUI Compass|April 18, 2024
Clinical variables associated with major adverse cardiac events following radical cystectomyAaron A Gurayah, Ruben Blachman-Braun, Christopher J Machado, et al.
Minerva Urology and Nephrology|February 7, 2020
Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysisJoshua S Jue, Tulay Koru-Sengul, Feng Miao, et al.
Cancers|October 28, 2023
The Influence of the Microbiome on Urological Malignancies: A Systematic ReviewJoao G Porto, Maria Camila Suarez Arbelaez, Brandon Pena, et al.
Urology|November 13, 2019
Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic AdenocarcinomaOleksii A Iakymenko, Isabella Lugo, Deukwoo Kwon, et al.
Pageof 39